New Infusion Suite at the Children's Hospital at Montefiore Blends Child-Friendly Design With Expert Cli... (r key members of the careteam including ...)

(Date:12/1/2008)...Sales More Than Doubled Over Prior Year Quarter --...reamlined Operations, and S...ure Exchange: NVC , , RICHMOND, BC, Dec. 1 ... a new specialty vascular device company, today an...d nine months ended September 30, 2008. , Neova...

(Date:12/1/2008)...c. 1 In the face of one of the mos...on, the Sutter Health Board of,Directors has appr... to fully,fund the Sutter Health Retirement Plan....invested in stocks and bonds, have been among the ...omy. Although conservatively,invested, the Sutter...

(Date:12/1/2008)...colleagues, at Memorial Sloan-Kettering Cancer Cen...dulate the expression of genes for therapeutic pur...er therapy in mice. , Small, noncoding RNA molec...rs of gene expression. In the study, the miRNA miR...es in immune cells known as T cells at different s...

(Date:12/1/2008)...essing miRNA natural gene repressors for anticance... Memorial Sloan-Kettering Cancer Center, New York,...ression of genes for therapeutic purposes, and use...mice. , Small, noncoding RNA molecules known as ...ression. In the study, the miRNA miR-181a was harn...

[0] Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results [0] Sutter Health Invests Hundreds of Millions in Employee Pension [0] Harnessing miRNA natural gene repressors for anticancer therapy [0] JCI online early table of contents: Dec. 1, 2008

...ays and after many comfortable winter evenings, ma...arly// on their hips, thighs and buttocks. But on...panic, said Isabelle Keller of the German Society ...hen people return to their usual nutritional habit...

...latest report published in Archives of Otolaryngol...attributed// to psychiatric or neurologic conditio...n and women who had suffered dizziness for an exte...n the age group of 15 to 89. It was found that 339...

...ay be smiling. Researchers have given their opinio...sarian operations//, those decided solely upon by ...cording to their results published in the Canadian... encountered by a woman who opts for a C-section, ...

...ons has determined that by modifying a classic lig... as baseball players//, to their prior level of co...ial collateral ligament (MCL), which links and sta...rm where they meet at the elbow. Less traumatic ...

Other Medicine News:Health News:Permanent Weight Loss Requires Transition to Healthy Eating 2 Health News:Modified Ligament Surgery Improves Outcomes Players, Athletes 2 Health News:Modified Ligament Surgery Improves Outcomes Players, Athletes 3

Permanent Weight Loss Requires Transition to Healthy Eating Dizziness Linked To Anxiety Disorders Mothers Opting for C-Sections- Be Warned Modified Ligament Surgery Improves Outcomes Players, Athletes

(Date:11/28/2008)..., Germany, November 28 German biot...ship in specialized HIV monitoring and,AIDS patie...ng countries. In,the year 2008, 2.5 million patie...obust and highly affordable "CyFlow" system, suppo...ith HIV/AIDS. Due to introduction of the,Partec i...

(Date:11/26/2008)...ed to 406 Subjects , , FRANKLIN, Mass., Nov...TC Bulletin Board: PLCSF) announced today that it ...Drug Administration (FDA) for its U.S. pivotal tri...alGuard System(TM) and associated therapy in the ..., , The FDA also approved PLC,s request to ...

(Date:11/25/2008)...ANCISCO, Calif., Nov. 25 ... a biopharmaceutical company focused on,innovativ... be exploring,strategic alternatives for its prec...ompany to focus its resources on the clinical deve..., and to support the initial commercialization of,...

(Date:11/24/2008)...ich., Nov. 24 Domino,s Pizza (NYSE...elivery, is gearing up to raise dough for,the kid...its fifth annual,Thanks and Giving campaign. Domi...a donation at point of purchase to benefit the chi...ering over the phone or when ordering online at, ...

Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2 PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2 PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3 PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4 Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2 Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3 Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2 Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3 Study in Circulation provides detail on how low blood flow promotes vascular disease 22506 1 Study in Circulation provides detail on how low blood flow promotes vascular disease 22506 2 Study in Circulation provides detail on how low blood flow promotes vascular disease 22506 3 STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump 22504 1 STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump 22504 2 STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump 22504 3 AMDL Announces Guidance for FY2008 22502 1 AMDL Announces Guidance for FY2008 22502 2 AMDL Announces Guidance for FY2008 22502 3 AMDL Announces Guidance for FY2008 22502 4 AMDL Announces Guidance for FY2008 22502 5 ULURU Inc Announces the Appointment of Ronald A Ahrens to the Board of Directors 22500 1 ULURU Inc Announces the Appointment of Ronald A Ahrens to the Board of Directors 22500 2

[0] German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 [0] PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.[0] Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin [1] Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign

...USINESS WIRE)--Jul 3, 2007 - Nymox,Pharmaceutical ...rther clinical results from the Company,s studies ...will be presented at the New,England Section of th...n in September. The paper is authored by leading c...trials of NX-107., The Company previously complete...

...ular Cell Show Potential of microRNAs as,Novel Can...ICK, New Jersey, July 05, 2007,/PRNewswire-FirstCa...ompany, announced today research published in the ...mann Institute of Science,and Rosetta Genomics . T...single microRNA (miR-34a) to be used as a drug can...

Other Medicine Technology:Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting 2 Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 2 Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 3 Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 4 Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 5

Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression

Holligard protects skin from irritating stomal discharge. Holligard is flexible and durable in heat and humidity.

Inquire

Contour I pouches are light as a feather and feature our tapered SoftFlex skin barrier for comformability, flexbility and comfort. All Contour I pouches have ComfortWear panels that keep skin cool an

Medicine Products:

HolliGard Seal Ring Closed Pouch Contour I Drainable Pouch, Oval Cut-to-Fit Skin Barrier Contour I Mini-Drainable Pouch, Cut-to-Fit Contour I Closed Pouch, Cut-to-Fit

New Infusion Suite at the Children's Hospital at Montefiore Blends Child-Friendly Design With Expert Cli...(r key members of the careteam including ...),Health